Structural basis of G protein-coupled receptor function

Molecular and Cellular Endocrinology

Volumn 151, Issue 1-2, 1999, Pages 181-193

  Schöneberg, Torsten ^a   Schultz, Günter ^a   Gudermann, Thomas ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Multiple coupling; Oligomerization; Receptor assembly; Trafficking

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR PROTEIN;

ALPHA HELIX; MOLECULAR BIOLOGY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0344241924     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00017-9     Document Type: Article

References (154)

1. s. J. Biol. Chem. 272:1997;14586-14591.
2. Acharya S., Karnik S.S. Modulation of GDP release from transducin by the conserved Glu134-Arg135 sequence in rhodopsin. J. Biol. Chem. 271:1996;25406-25411.
3. Alblas J., van Etten I., Khanum A., Moolenaar W.H. C-terminal truncation of the neurokinin-2 receptor causes enhanced and sustained agonist-induced signaling. Role of receptor phosphorylation in signal attenuation. J. Biol. Chem. 270:1995;8944-8951.
4. Altenbach C., Yang K., Farrens D.L., Farahbakhsh Z.T., Khorana H.G., Hubbell W.L. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. Biochemistry. 35:1996;12470-12478.
5. Amatruda T.T., Dragas-Graonic S., Holmes R., Perez H.D. Signal transduction by the formyl peptide receptor. Studies using chimeric receptors and site-directed mutagenesis define a novel domain for interaction with G-proteins. J. Biol. Chem. 270:1995;28010-28030.
6. Arey B.J., Stevis P.E., Deecher D.C., Shen E.S., Frail D.E., Negro-Vilar A., Lopez F.J. Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms. Mol. Endocrinol. 11:1997;517-526.
7. Arnis S., Fahmy K., Hofmann K.P., Sakmar T.P. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J. Biol. Chem. 269:1994;23879-23881.
8. Arora K.K., Cheng Z., Catt K.J. Dependence of agonist activation on an aromatic moiety in the DPLIY motif of the gonadotropin-releasing hormone receptor. Mol. Endocrinol. 10:1996;979-986.
9. Arora K.K., Cheng Z., Catt K.J. Mutations of the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation, and internalization. Mol. Endocrinol. 11:1997;1203-1212.
10. Avissar S., Amitai G., Sokolovsky M. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. Proc. Natl. Acad. Sci. USA. 80:1983;156-159.
11. Awara W.M., Guo C.H., Conn P.M. Effects of Asn318 and Asp87 Asn318 mutations on signal transduction by the gonadotropin-releasing hormone receptor and receptor regulation. Endocrinology. 137:1996;655-662.
12. Bai M., Trivedi S., Brown E.M. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J. Biol. Chem. 273:1998;23605-23610.
13. Baker E.K., Colley N.J., Zuker C.S. The cyclophilin homolog NinaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin. EMBO J. 13:1994;4886-4896.
14. Baldwin J.M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12:1993;1693-1703.
15. Baldwin J.M. Structure and function of receptors coupled to G proteins. Curr. Opin. Cell. Biol. 6:1994;180-190.
16. Beck M., Sakmar T.P., Siebert F. Spectroscopic evidence for interaction between transmembrane helices 3 and 5 in rhodopsin. Biochemistry. 37:1998;7630-7639.
17. Benkirane M., Jin D.Y., Chun R.F., Koup R.A., Jeang K.T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32. J. Biol. Chem. 272:1997;30603-30606.
18. Berkower C., Michaelis S. Mutational analysis of the yeast a-factor transporter STE6, a member of the ATP binding cassette (ABC) protein superfamily. EMBO J. 10:1991;3777-3785.
19. Bibi E., Kaback H.R. In vivo expression of the lacY gene in two segments leads to functional lac permease. Proc. Natl. Acad. Sci. USA. 87:1990;4325-4329.
20. Biebermann H., Schöneberg T., Schulz A., Krause G., Grüters A., Schultz G., Gudermann T. A conserved tyrosine residue (Y601) in transmembrane domain 5 determines of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB J. 12:1998;1461-1471.
21. q/11 by the m3 muscarinic acetylcholine receptor. J. Biol. Chem. 270:1995;17741-17748.
22. Blüml K., Mutschler E., Wess J. Identification of an intracellular tyrosine residue critical for muscarinic receptor-mediated stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem. 269:1994;402-405.
23. Bonifacino J.S., Cosson P., Shah N., Klausner R.D. Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum. EMBO J. 10:1991;2783-2793.
24. Cetani F., Tonacchera M., Vassart G. Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors. FEBS Lett. 378:1996;27-31.
25. Colley N.J., Cassill J.A., Baker E.K., Zuker C.S. Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration. Proc. Natl. Acad. Sci. USA. 92:1995;3070-3074.
26. iα Nature. 363:1993;274-276.
27. Conn P.M., Venter J.C. Radiation inactivation (target size analysis) of the gonadotropin-releasing hormone receptor: evidence for a high molecular weight complex. Endocrinology. 116:1985;1324-1326.
28. Cope D.L., Holman G.D., Baldwin S.A., Wolstenholme A.J. Domain assembly of the GLUT1 glucose transporter. Biochem. J. 300:1994;291-294.
29. Cvejic S., Devi L.A. Dimerization of the δ opioid receptor: implication for a role in receptor internalization. J. Biol. Chem. 272:1997;26959-26964.
30. 2-adrenergic receptor to different G proteins by protein kinase A. Nature. 390:1997;88-91.
31. Elling C.E., Nielsen S.M., Schwartz T.W. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor. Nature. 374:1995;74-77.
32. Elling C.E., Schwartz T.W. Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering. EMBO J. 15:1996;6213-6219.
33. s coupling selectivity. J. Biol. Chem. 273:1998;26549-26558.
34. Farahbakhsh Z.T., Ridge K.D., Khorana H.G., Hubbell W.L. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. Biochemistry. 34:1995;8812-8819.
35. Farrens D.L., Altenbach C., Yang K., Hubbell W.L., Khorana H.G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science. 274:1996;768-770.
36. Ferreira P.A., Nakayama T.A., Pak W.L., Travis G.H. Cyclophilin-related protein RanBP2 acts as a chaperone for red/green opsin. Nature. 383:1996;637-640.
37. Franke R.R., Sakmar T.P., Graham R.M., Khorana H.G. Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin. J. Biol. Chem. 267:1992;14767-14774.
38. Gerald C., Walker M.W., Criscione L. et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
39. 2 adrenergic receptor. Evidence for ligand-specific conformational changes. J. Biol. Chem. 270:1995;28268-28275.
40. 2 adrenoceptor. EMBO J. 16:1997;6737-6747.
41. Gilchrist R.L., Ryu K.S., Ji I., Ji T.H. The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. J. Biol. Chem. 271:1996;19283-19287.
42. Grosse R., Schöneberg T., Schultz G., Gudermann T. Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. Mol. Endocrinol. 11:1997;1305-1318.
43. Gudermann T., Kalkbrenner F., Schultz G. Diversity and selectivity of receptor-G protein interaction. Annu. Rev. Pharmacol. Toxicol. 36:1996;429-459.
44. Gudermann T., Schöneberg T., Schultz G. Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu. Rev. Neurosci. 20:1997;399-427.
45. Hartl F.U. Molecular chaperones in cellular protein folding. Nature. 381:1996;571-579.
46. Hartmann E., Rapoport T.A., Lodish H.F. Predicting the orientation of eukaryotic membrane-spanning proteins. Proc. Natl. Acad. Sci. USA. 86:1989;5786-5790.
47. Hausdorff W.P., Caron M.G., Lefkowitz R.J. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4:1990;2881-2889.
48. Hawes B.E., Luttrell L.M., Exum S.T., Lefkowitz R.J. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J. Biol. Chem. 269:1994;15776-45785.
49. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271:1996;16384-16392.
50. Hebert T.E., Bouvier M. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem. Cell. Biol. 76:1998;1-10.
51. Helmreich E.J., Hofmann K.P. Structure and function of proteins in G-protein-coupled signal transfer. Biochim. Biophys. Acta. 1286:1996;285-322.
52. i proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C. J. Biol. Chem. 271:1996;16764-16772.
53. Hipkin R.W., Liu X., Ascoli M. Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist- or phorbol ester-induced receptor phosphorylation and uncoupling. J. Biol. Chem. 270:1995;26683-26689.
54. Huang K.S., Bayley H., Liao M.J., London E., Khorana H.G. Refolding of an integral membrane protein. Denaturation, renaturation, and reconstitution of intact bacteriorhodopsin and two proteolytic fragments. J. Biol. Chem. 256:1981;3802-3809.
55. Iida-Klein A., Guo J., Xie L.Y. et al. Truncation of the carboxyl-terminal region of the rat parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of adenylyl cyclase but not phospholipase C. J. Biol. Chem. 270:1995;8458-8465.
56. Ishihara H., Connolly A.J., Zeng D. et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 386:1997;502-506.
57. Jähnig F. Thermodynamics and kinetics of protein incorporation into membranes. Proc. Natl. Acad. Sci. USA. 80:1983;3691-3695.
58. Janssens R., Communi D., Pirotton S., Samson M., Parmentier M., Boeynaems J.M. Cloning and tissue distribution of the human P2Y1 receptor. Biochem. Biophys. Res. Commun. 221:1996;588-593.
59. Jaquette J., Segaloff D.L. Temperature sensitivity of some mutants of the lutropin/choriogonadotropin receptor. Endocrinology. 138:1997;85-91.
60. 11]substance P acts as a biased agonist toward neuropeptide and chemokine receptors. J. Biol. Chem. 273:1998;3097-3104.
61. 2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment. J. Biol. Chem. 272:1997;18546-18549.
62. Jones K.A., Borowsky B., Tamm J.A. et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature. 396:1998;674-679.
63. Jones P.G., Curtis C.A.M., Hulme E.C. The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor. Eur. J. Pharmacol. 288:1995;251-257.
64. Jung H., Windhaber R., Palm D., Schnackerz K.D. NMR and circular dichroism studies of synthetic peptides derived from the third intracellularloop of the β-adrenoceptor. FEBS Lett. 358:1995;133-136.
65. 1H-NMR spectroscopy. Biochemistry. 35:1996;6399-6405.
66. Kahn T.W., Engelman D.M. Bacteriorhodopsin can be refolded from two independently stable transmembrane helices and the complementary five-helix fragment. Biochemistry. 31:1992;6144-6151.
67. B receptors uncovers similarity to metabotropic glutamate receptors. Nature. 386:1997;239-246.
68. Kaupmann K., Malitschek B., Schuler V. et al. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature. 396:1998;683-687.
69. 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J. Biol. Chem. 267:1992;1430-1433.
70. 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science. 240:1988;1310-1316.
71. o-mediated phototransduction cascade in scallop visual cells. J. Biol. Chem. 272:1997;22979-22982.
72. q coupling selectivity. J. Biol. Chem. 272:1997;23675-23681.
73. Kostenis E., Zeng F.Y., Wess J. Functional characterization of a series of mutant G protein α subunits displaying promiscuous receptor coupling properties. J. Biol. Chem. 273:1998;17886-17892.
74. Köster W., Braun V. Iron(III) hydroxamate transport of Escherichia coli: restoration of iron supply by coexpression of the N- and C-terminal halves of the cytoplasmic membrane protein FhuB cloned on separate plasmids. Mol. Gen. Genet. 223:1990;379-384.
75. Kosugi S., Mori T., Shenker A. The role of Asp578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. J. Biol. Chem. 271:1996;31813-31817.
76. Kosugi S., Mori T., Shenker A. An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. Mol. Pharmacol. 53:1998;894-901.
77. Laburthe M., Couvineau A., Gaudin P., Maoret J.J., Rouyer-Fessard C., Nicole P. Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor. Ann. NY Acad. Sci. 805:1996;94-111.
78. Laugwitz K.L., Spicher K., Schultz G., Offermanns S. Identification of receptor-activated G proteins: selective immunoprecipitation of photolabeled G-protein α subunits. Methods Enzymol. 237:1994;283-294.
79. Laugwitz K.L., Allgeier A., Offermanns S. et al. The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc. Natl. Acad. Sci. USA. 93:1996;116-120.
80. Lefkowitz R.J., Cotecchia S., Samama P., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:1993;303-307.
81. Lemmon M.A., Flanagan J.M., Treutlein H.R., Zhang J., Engelman D.M. Sequence specificity in the dimerization of transmembrane α-helices. Biochemistry. 31:1992;12719-12725.
82. Lemmon M.A., Treutlein H.R., Adams P.D., Brunger A.T., Engelman D.M. A dimerization motif for transmembrane α-helices. Nat. Struct. Biol. 1:1994;157-163.
83. Lemmon M.A., Schlessinger J. Transmembrane signaling by receptor oligomerization. Methods Mol. Biol. 84:1998;49-71.
84. Lin Z., Shenker A., Pearlstein R. A model of the lutropin/choriogonadotropin receptor: insights into the structural and functional effects of constitutively activating mutations. Protein Eng. 10:1997;501-510.
85. Liu J., Schöneberg T., van Rhee M., Wess J. Mutational analysis of the relative orientation of transmembrane helices I and VII in G protein-coupled receptors. J. Biol. Chem. 270:1995a;19532-19539.
86. Liu J., Conklin B.R., Blin N., Yun J., Wess J. Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. Proc. Natl. Acad. Sci. USA. 92:1995b;11642-11646.
87. Liu J., Wess J. Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family. J. Biol. Chem. 271:1996;8772-8778.
88. Maggio R., Vogel Z., Wess J. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular crosstalk between G protein-linked receptors. Proc. Natl. Acad. Sci. USA. 90:1993a;3103-3107.
89. Maggio R., Vogel Z., Wess J. Reconstitution of functional muscarinic receptors by co-expression of amino- and carboxyl-terminal receptor fragments. FEBS Lett. 319:1993b;195-200.
90. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
91. Mitchell R., McCulloch D., Lutz E. et al. Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature. 392:1998;411-414.
92. Mizobe T., Maze M., Lam V., Suryanarayana S., Kobilka B.K. Arrangement of transmembrane domains in adrenergic receptors. Similarity to bacteriorhodopsin. J. Biol. Chem. 271:1996;2387-2389.
93. Monnot C., Bihoreau C., Conchon S., Curnow K.M., Corvol P., Clauser E. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J. Biol. Chem. 271:1996;1507-1513.
94. Nakamura M., Honda Z., Izumi T. et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 266:1991;20400-20405.
95. 2 receptor dimers and receptor-blocking peptides. Biochem. Biophys. Res. Commun. 227:1996;200-204.
96. 2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. Endocrinology. 138:1997;4199-4206.
97. 3 receptor dimers and tetramers in brain and in transfected cells. J. Biol. Chem. 272:1997;29229-29237.
98. Nystedt S., Emilsson K., Larsson A.K., Strombeck B., Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur. J. Biochem. 232:1995;84-89.
99. 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell. 67:1991;723-730.
100. 2-adrenergic receptors based upon characteristics in primary structure. J. Biol. Chem. 267:1992;8342-8346.
101. s-protein by site-specific synthetic peptides. FEBS Lett. 254:1989;89-93.
102. Pittel Z., Wess J. Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors. Mol. Pharmacol. 45:1994;61-64.
103. Popot J.L., Engelman D.M. Membrane protein folding and oligomerization: the two-stage model. Biochemistry. 29:1990;4031-4037.
104. 1b-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint. J. Biol. Chem. 271:1996;28318-28323.
105. Rapoport T.A., Jungnickel B., Kutay U. Protein transport across the eukaryotic endoplasmic reticulum and bacterial inner membranes. Annu. Rev. Biochem. 65:1996;271-303.
106. Robinson P.R., Cohen G.B., Zhukovsky E.A., Oprian D.D. Constitutively active mutants of rhodopsin. Neuron. 9:1992;719-725.
107. Romano C., Yang W.L., O'Malley K.L. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem. 271:1996;28612-28616.
108. 2 vasopressin receptor unable to stimulate adenylyl cyclase. J. Biol. Chem. 268:1993;13030-13033.
109. Rozell T.G., Davis D.P., Chai Y., Segaloff D.L. Association of gonadotropin receptor precursors with the protein folding chaperone calnexin. Endocrinology. 139:1998;1588-1593.
110. 2R expression. Mol. Endocrinol. 11:1997;706-713.
111. Samson M., Libert F., Doranz B.J. et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725.
112. Saunders C., Keefer J.R., Bonner C.A., Limbird L.E. Targeting of G protein-coupled receptors to the basolateral surface of polarized renal epithelial cells involves multiple, non-contiguous structural signals. J. Biol. Chem. 273:1998;24196-24206.
113. Sawzdargo M., George S.R., Nguyen T., Xu S., Kolakowski L.F., O'Dowd B.F. A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem. Biophys. Res. Commun. 239:1997;543-547.
114. 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J. 15:1996;3566-3578.
115. 1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc. Natl. Acad. Sci. USA. 9:1997;808-813.
116. Schertler G.F., Villa C., Henderson R. Projection structure of rhodopsin. Nature. 362:1993;770-772.
117. 3-receptor pre-mRNA in chronic schizophrenia. J. Neurosci. 16:1996;7902-7909.
118. Schöneberg T., Liu J., Wess J. Plasma membrane localization and functional rescue of truncated forms of a G protein-coupled receptor. J. Biol. Chem. 270:1995;18000-18006.
119. 2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J. 15:1996;1283-1291.
120. 2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. J. Clin. Invest. 100:1997;1547-1556.
121. 2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms. Hum. Mutat. 12:1998;196-205.
122. 2 receptor are essential for cell surface transport in COS.M6 cells. Mol. Pharmacol. 54:1998;525-535.
123. Schulz A., Schöneberg T., Paschke R., Schultz G., Gudermann T. Contribution of the third intracellular loop in stabilizing the inactive receptor conformation of the glycoprotein hormone receptors. Mol. Endocrinol. 13:1999;181-190.
124. 2A receptor. J. Biol. Chem. 270:1995;16683-16688.
125. Sheikh S.P., Zvyaga T.A., Lichtarge O., Sakmar T.P., Bourne H.R. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature. 383:1996;347-350.
126. Shen D., Jiang M., Hao W., Tao L., Salazar M., Fong H.K. A human opsin-related gene that encodes a retinaldehyde-binding protein. Biochemistry. 33:1994;13117-13125.
127. Shenker A. G protein-coupled receptor structure and function: the impact of disease-causing mutations. Baillieres Clin. Endocrinol. Metab. 9:1995;427-451.
128. Simon M.I., Strathmann M.P., Gautam N. Diversity of G proteins in signal transduction. Science. 252:1991;802-808.
129. Spiegel A.M. Defects in G protein-coupled signal transduction in human disease. Annu. Rev. Physiol. 58:1996;143-170.
130. Strader C.D., Fong T.M., Tota M.R., Underwood D., Dixon R.A. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:1994;101-132.
131. Stühmer W., Conti F., Suzuki H. et al. Structural parts involved in activation and inactivation of the sodium channel. Nature. 339:1989;597-603.
132. 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science. 257:1992;977-980.
133. Suryanarayana S., von Zastrow M., Kobilka B.K. Identification of intramolecular interactions in adrenergic receptors. J. Biol. Chem. 267:1992;21991-21994.
134. Takagi Y., Ninomiya H., Sakamoto A., Miwa S., Masaki T. Structural basis of G protein specificity of human endothelin receptors. A study with endothelin A/B chimeras. J. Biol. Chem. 270:1995;10072-10078.
135. Tang W.J., Stanzel M., Gilman A.G. Truncation and alanine-scanning mutants of type I adenylyl cyclase. Biochemistry. 34:1995;14563-14572.
136. Thirstrup K., Elling C.E., Hjorth S.A., Schwartz T.W. Construction of a high affinity zinc switch in the κ-opioid receptor. J. Biol. Chem. 271:1996;7875-7878.
137. 1B receptor subtype. J. Biol. Chem. 269:1994;27925-27931.
138. Unger V.M., Hargrave P.A., Baldwin J.M., Schertler G.F. Arrangement of rhodopsin transmembrane α-helices. Nature. 389:1997;203-206.
139. Unson C.G., Cypess A.M., Kim H.N., Goldsmith P.K., Carruthers C.J., Merrifield R.B., Sakmar T.P. Characterization of deletion and truncation mutants of the rat glucagon receptor. Seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding. J. Biol. Chem. 270:1995;27720-27727.
140. 1-adrenergic receptor structure. Mol. Pharmacol. 26:1984;196-205.
141. Wang Z., Wang H., Ascoli M. Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/chorionic gonadotropin receptor. Mol. Endocrinol. 7:1993;85-93.
142. Ward D.T., Brown E.M., Harris H.W. Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J. Biol. Chem. 273:1998;14476-14483.
143. Watson, S., Arkinstall, S., 1994. In: Watson S, Arkinstall S, editors. The G-Protein linked Receptor Facts Book. London: Academic Press, pp. 1-291.
144. Wells J.A. Binding in the growth hormone receptor complex. Proc. Natl. Acad. Sci. USA. 93:1996;1-6.
145. Wenkert D., Schöneberg T., Merendino J.J. et al. Functional characterization of five V2 vasopressin receptor gene mutations. Mol. Cell. Endocrinol. 124:1996;43-50.
146. Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J. 11:1997;346-354.
147. Wess J. Molecular basis of receptor/G protein coupling selectivity. Pharmacol. Ther. 80:1998;237-264.
148. White J.H., Wise A., Main M.J. et al. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature. 396:1998;679-682.
149. Wonerow P., Schöneberg T., Schultz G., Gudermann T., Paschke R. Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation. J. Biol. Chem. 273:1998;7900-7905.
150. Wu V., Yang M., McRoberts J.A. et al. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells. J. Biol. Chem. 272:1997;9037-9042.
151. Yeagle P.L., Alderfer J.L., Albert A.D. Three-dimensional structure of the cytoplasmic face of the G protein receptor rhodopsin. Biochemistry. 36:1997a;9649-9654.
152. Yeagle P.L., Alderfer J.L., Salloum A.C., Ali L., Albert A.D. The first and second cytoplasmic loops of the G-protein receptor, rhodopsin, independently form β-turns. Biochemistry. 36:1997b;3864-3869.
153. Zhou W., Flanagan C., Ballesteros J.A. et al. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol. Pharmacol. 45:1994;165-170.
154. Zhu S.Z., Wang S.Z., Hu J., el-Fakahany E.E. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. Mol. Pharmacol. 45:1994;517-523.